Lijun Fang Selected Research

Lijun Fang Research Topics

Disease

7	Neoplasms (Cancer) 12/2022 - 01/2017
3	Mitochondrial Diseases (Mitochondrial Disease) 04/2021 - 05/2017
2	Infections 11/2023 - 03/2014
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2023 - 06/2023
2	Hypoxia (Hypoxemia) 01/2022 - 01/2016
2	Disease Progression 01/2020 - 09/2016
1	Hematologic Diseases (Blood Diseases) 11/2023
1	COVID-19 11/2023
1	Pneumonia (Pneumonitis) 11/2023
1	Essential Thrombocythemia 01/2023
1	Infarction (Infarctions) 01/2022
1	Lung Injury 04/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Hypertrophy 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy) 01/2020
1	Cardiomyopathies (Cardiomyopathy) 09/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Genomic Instability 01/2019
1	Carcinogenesis 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2016
1	Wounds and Injuries (Trauma) 07/2007

Drug/Important Bio-Agent (IBA)

3	CollagenIBA 01/2022 - 01/2021
2	Inosine Triphosphate (ITP)IBA 11/2023 - 06/2023
2	RadonIBA 04/2021 - 01/2019
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021 - 09/2019
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2017
2	AntioxidantsIBA 01/2021 - 09/2019
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	ElastinIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 04/2021
1	Adenosine Triphosphate (ATP)IBA 04/2021
1	MelatoninIBA 04/2021
1	Superoxide DismutaseIBA 04/2021
1	Caspase 3 (Caspase-3)IBA 04/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Angiotensin IIIBA 01/2021
1	7- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA 01/2021
1	Squalene Monooxygenase (Squalene Epoxidase)IBA 01/2021
1	scoparoneIBA 01/2021
1	rac1 GTP-Binding ProteinIBA 01/2021
1	osthol (osthole)IBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	NAD (NADH)IBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2019
1	astragaloside AIBA 09/2019
1	CarcinogensIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 05/2017
1	nonylphenolIBA 05/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	LY3009120IBA 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 09/2016
1	Interleukin-7 (Interleukin 7)IBA 09/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2007
1	Saline SolutionIBA 07/2007
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2007
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 07/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2007
1	Epidermal Growth Factor (EGF)IBA 07/2007
1	von Willebrand FactorIBA 07/2007

Therapy/Procedure

4	Therapeutics 11/2023 - 01/2020
1	Skin Transplantation (Skin Grafting) 07/2007